MorphoSys AG
MPSYF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,229 | $457 | $1,107 | $3,056 |
| - Cash | $159 | $402 | $123 | $110 |
| + Debt | $636 | $339 | $326 | $318 |
| Enterprise Value | $1,707 | $394 | $1,309 | $3,264 |
| Revenue | $238 | $278 | $180 | $328 |
| % Growth | -14.4% | 54.9% | -45.2% | – |
| Gross Profit | $180 | $230 | $147 | $319 |
| % Margin | 75.5% | 82.5% | 82.1% | 97.2% |
| EBITDA | -$98 | $173 | -$331 | $128 |
| % Margin | -41% | 62.1% | -184.4% | 39% |
| Net Income | -$190 | -$151 | -$515 | $98 |
| % Margin | -79.6% | -54.3% | -286.5% | 29.9% |
| EPS Diluted | -5.53 | -4.42 | -15.4 | 2.97 |
| % Growth | -25.1% | 71.3% | -618.5% | – |
| Operating Cash Flow | -$296 | -$367 | -$481 | $35 |
| Capital Expenditures | -$3 | -$15 | -$26 | -$49 |
| Free Cash Flow | -$299 | -$382 | -$508 | -$14 |